27 January 2023 - Since the beginning of the vaccine rollout to 22 January 2023, almost 65 million doses of COVID-19 ...
26 January 2023 - In the final analysis of the Phase 3 clinical study conducted by Veru, sabizabulin showed a 51.6% ...
26 January 2023 - The US FDA has stated that AstraZeneca’s Evusheld (tixagevimab and cilgavimab) is not currently authorised for ...
23 January 2023 - On 20 January 2023, the TGA granted provisional approval to Pfizer’s bivalent COVID-19 vaccine: tozinameran and famtozinameran ...
12 January 2023 - Since the beginning of the vaccine rollout to 8 January 2023, almost 65 million doses of COVID-19 ...
9 January 2023 - Commercial price is similar to Pfizer’s plans for after government contracting ends. ...
22 December 2022 - This is an abbreviated version of the COVID-19 vaccine safety report. ...
21 December 2022 - Actemra is the first FDA approved monoclonal antibody to treat COVID-19. ...
15 December 2022 - To 11 December 2022, the TGA has received 706 reports which have been assessed as likely to ...
9 December 2022 - Today, Health Canada authorised the Pfizer-BioNTech Comirnaty Omicron BA.4/BA.5 bivalent adapted booster for use in children 5 ...
9 December 2022 - Pfizer and BioNTech today announced the companies have received fast track designation from the US FDA ...
8 December 2022 - Today, the US FDA amended the emergency use authorisations of the updated (bivalent) Moderna and Pfizer-BioNTech COVID-19 ...
6 December 2022 - The United States on Tuesday urged delaying a decision on whether to waive patent protection for ...
7 December 2022 - Novavax today announced that Health Canada has approved a supplement to a new drug submission for Nuvaxovid ...
6 December 2022 - EMA’s Emergency Task Force considers that adapted mRNA bivalent vaccines targeting the original strain and Omicron ...